C.M. Bidwell & Associates’s Merck MRK Stock Holding History

C.M. Bidwell & Associates’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.08K	Hold	24	–	–	﹤0.01%	383
2026 Q1	$2.89K	Hold	24	–	–	﹤0.01%	377
2025 Q4	$2.53K	Hold	24	–	–	﹤0.01%	377
2025 Q3	$2.01K	Buy	+24	New	+$1.98K	﹤0.01%	400
2023 Q3	–	Sell	-1,282	Closed	-$148K	–	567
2023 Q2	$148K	Hold	1,282	–	–	0.11%	165
2023 Q1	$136K	Sell	1,282 -2,771	-68%	-$299K	0.1%	176
2022 Q4	$450K	Sell	4,053 -20	-0.5%	-$2.04K	0.35%	46
2022 Q3	$351K	Sell	4,073 -469	-10%	-$41.9K	0.29%	54
2022 Q2	$414K	Buy	4,542 +1,212	+36%	+$107K	0.33%	47
2022 Q1	$273K	Buy	+3,330	New	+$263K	0.18%	103
2020 Q2	–	Sell	-3,940	Closed	-$289K	–	442
2020 Q1	$289K	Buy	3,940 +665	+20%	+$52.3K	0.3%	85
2019 Q4	$284K	Sell	3,275 -80	-2%	-$6.57K	0.26%	86
2019 Q3	$269K	Buy	3,355 +1,348	+67%	+$108K	0.27%	98
2019 Q2	$161K	Buy	2,007 +1,530	+321%	+$117K	0.16%	135
2019 Q1	$38K	Buy	+477	New	+$35.7K	0.04%	271
2015 Q1	–	Sell	-5,361	Closed	-$290K	–	248
2014 Q4	$290K	Buy	+5,361	New	+$299K	0.07%	131

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

C.M. Bidwell & Associates's MRK Position: Q2 2026 in Review

C.M. Bidwell & Associates held its Merck (MRK) position steady in Q2 2026 at 24 shares worth $3.08K. The position accounts for ﹤0.01% of the portfolio, ranked #383.

C.M. Bidwell & Associates first reported a position in MRK in Q4 2014 and has held it in 16 quarters since. The position peaked at $450K in Q4 2022. 3,839 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

C.M. Bidwell & Associates held 24 shares of Merck worth $3.08K as of Q2 2026.
C.M. Bidwell & Associates left its Merck share count unchanged in Q2 2026.
Merck made up ﹤0.01% of C.M. Bidwell & Associates's portfolio in Q2 2026, its #383 holding.
C.M. Bidwell & Associates first reported a position in Merck in Q4 2014 and has held it in 16 quarters since.
C.M. Bidwell & Associates's Merck position peaked at $450K in Q4 2022.
3,839 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on C.M. Bidwell & Associates's 13F filing for Q2 2026, filed 11 Aug 2026.